Learn More
Medchemexpress LLC IMMH-010 maleate | 2541982-47-0 | 99.8% | 756.04 | 1 MG

Supplier: Medchemexpress LLC HY1678401MG
IMMH-010 maleate is a prodrug that serves as a novel PD-L1 inhibitor, exhibiting potential antitumor activity for the treatment of neurological disorders and advanced malignant solid tumors. It is rapidly converted to its active form, YPD-29B, following oral administration. IMMH-010 maleate is poised for advancing research in the field of PD-L1 inhibitors and related therapeutic applications.
- Novel PD-L1 inhibitor
- Exhibits potential antitumor activity for neurological disorders and advanced malignant solid tumors
- Prodrug that rapidly converts to its active form, YPD-29B, following oral administration
- Poised for advancing research in the field of PD-L1 inhibitors and related therapeutic applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.